Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Bortezomib × Clear all

NCT00064610 2008-02-11

Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms